Patient Education
Share your love
Kriya Therapeutics raises $313.3 funding
(Image credit: ©Hand Robot/AdobeStock) Kriya Therapeutics reported in an SEC filing it has raised $313.3 million in a recent funding round.1 The filing does not detail fund specificity or funding sources but rather only states two investors participated in the…
Racial and ethnic disparities in retinoblastoma treatment options
Vivienne S. Hau, MD, PhD, a vitreoretinal surgeon and faculty member at the Bernard J Tyson School of Medicine, Kaiser Permanente Med School, and also at the California University of School of Medicine, presented research on racial and ethnic disparities…
Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections
(Image credit: AdobeStock/marchsirawit) When propofol is used to sedate patients and during periocular injection, the stage may be set for a sneeze reflex, an unexpected movement that can cause needle injury to the globe or optic nerve or a hematoma.…
Neighborhood-level characteristics associated with delay in surgery and loss to follow-up
Sally S. Ong, MD, an assistant professor of ophthalmology at Atrium Health Wake Forest Baptist School of Medicine, presented research examining the relationship between neighborhood-level social determinants of health and disease severity in patients with tractional retinal detachments (TRD) associated…
Cannula vs needle in tear trough treatment
(Image Credit: AdobeStock/ME Image) Tear trough filler remains a topic of debate among some surgeons due to concerns about complications such as edema, malar mound accentuation, and vascular compromise. Nonetheless, this treatment has continuously proven to be an effective tool…
Alcon presenting at APACRS 2025
(Image credit: ©RealityImages/AdobeStock) Alcon announced presentations during the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone booth.1 APACRS…
The risk of sight-threatening diabetic retinopathy with GLP-1 RA use
Andy J. Barkmeier, MD, an associate professor of ophthalmology and vitreoretinal surgery at Mayo Clinic in Rochester, Minnesota, presented findings on GLP-1 medications and their relationship to diabetic retinopathy complications at the 2025 ASRS meeting in Long Beach, California. He…
The emerging era of presbyopia-correcting eye drops: What’s next?
(Image Credit: AdobeStock/taffpixture) Since 2021, only 1 prescription eye drop for the correction of presbyopia, pilocarpine HCI ophthalmic solution 1.25% (Vuity; AbbVie), has been available, with additional options expected soon. In early 2025, a second eye drop, pilocarpine HCI ophthalmic…
AEVR’s executive director on #SeeWhatMatters and safeguarding the National Eye Institute
#SeeWhatMatters is a national advocacy campaign to raise awareness about the importance of federally funded vision research and to protect the independence of the National Eye Institute amid proposed structural changes to the NIH. (Image courtesy of #SeeWhatMatters) The Alliance…
Study establishes reference data set for geographic atrophy lesion progression
(Image Credit: AdobeStock/tadamichi) The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with fovea-sparing, multifocal, and bilateral lesions having the fastest growth rates in a study published in Translational Vision Science &…